Impact of Vitamin D Supplementation in Acute and Chronic Immune Thrombocytopenia in Children. | ||||
Minia Journal of Medical Research | ||||
Article 35, Volume 30, Issue 3, July 2019, Page 173-176 PDF (418.81 K) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/mjmr.2022.221922 | ||||
View on SCiNiTO | ||||
Authors | ||||
Mostafa A. Elfouly1; Sheren E. Maher1; Waleed M. Abd El Hameed2; Ibrahim Y. Shihata1 | ||||
1Department of Pediatrics, El-Minia Faculty of Medicine | ||||
2Department of Clinical Pathology, El-Minia Faculty of Medicine | ||||
Abstract | ||||
Introduction: Immune thrombocytopenia (ITP) is the commonest cause of pediatric thrombocytopenia. Vitamin D (VD) is multifunctional hormone that regulates multiple activities in human body especially in immune system. Aim of the work: to investigate the role of VD as an immune modulating drug in the treatment of ITP in children. Patients and Methods: This cohort study was carried out on 80 patients with ITP. Cases are taken and divided into: Group I: It includes 40 children with acute ITP. They were subdivided into: Group I.A: 20 children will receive VD supplementation & Group I.B: 20 children will not receive VD. Group II: It includes 40 children with chronic ITP. They were subdivided into: Group II.A: 20 children will receive VD supplementation & Group II.B: 20 children will not receive VD. Results: VD level was low in all cases. VD supplementation improved platelets count. Discussion: VD deficiency may contribute to pathogenesis of ITP. VD supplementation was beneficial for acute and chronic ITP in children. Recommendation: Based on the current study we recommend VD assay in all cases of ITP to detect deficiency and give supplementation. | ||||
Keywords | ||||
ITP: Immune thrombocytopenia; VD: Vitamin D | ||||
Supplementary Files
|
||||
Statistics Article View: 104 PDF Download: 1,250 |
||||